All In Biotech

Investigational drug · Phase 3

JNJ-78934804

Also called: JNJ-4804

Not approved by FDA. In 4 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Colitis, Ulcerative, Crohn's Disease, Crohn Disease.

Phase 3

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

4

4 still active

All registered trials

4

Any phase or sponsor naming "JNJ-78934804"

First trial start

2022

Jul 22, 2022

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "JNJ-78934804", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Colitis, Ulcerative
  • Crohn's Disease
  • Crohn Disease

Approved drugs for the same conditions: Crohn's disease · Immunology and inflammation

Largest trials

Live from ClinicalTrials.gov: studies naming "JNJ-78934804" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 0 on PubMed

No PubMed records name it yet, which is common for early code-named drugs.

Also in development for Colitis, Ulcerative

  • DuvakitugSAR447189, TEV-48574 APhase 36 trials

    Sanofi · Ulcerative Colitis, Crohn's Disease, Hidradenitis

  • MORF-057zotemtegrast, LY4268989Phase 24 trials

    Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) · Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis (UC)

  • LY4395089Phase 22 trials

    Eli Lilly · Crohn Disease, Colitis, Ulcerative

  • SPY001SPY001-001Phase 22 trials

    Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis

  • SPY002SPY002-091Phase 22 trials

    Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis

  • SPY003SPY003-207Phase 22 trials

    Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from Johnson & Johnson (Janssen).

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.